Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56451 - 56475 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	NR2F2	7026	downregulated	panobinostat results in decreased expression of NR2F2 mRNA	15q26.2	A21037
Panobinostat	Approved Investigational	NRG1	3084	downregulated	panobinostat results in decreased expression of NRG1 mRNA	8p12	A21037
Panobinostat	Approved Investigational	NRIP1	8204	upregulated	panobinostat results in increased expression of NRIP1 mRNA	21q11.2-q21.1	A21037
Panobinostat	Approved Investigational	NRIP3	56675	downregulated	panobinostat results in decreased expression of NRIP3 mRNA	11p15.4	A21037
Panobinostat	Approved Investigational	NRP1	8829	upregulated	panobinostat results in increased expression of NRP1 mRNA	10p11.22	A21037
Panobinostat	Approved Investigational	NSD2	7468	downregulated	panobinostat results in decreased expression of NSD2 mRNA	4p16.3	A21037
Panobinostat	Approved Investigational	NTN4	59277	downregulated	panobinostat results in decreased expression of NTN4 mRNA	12q22	A21037
Panobinostat	Approved Investigational	NUAK2	81788	downregulated	panobinostat results in decreased expression of NUAK2 mRNA	1q32.1	A21037
Panobinostat	Approved Investigational	NUDT4	11163	upregulated	panobinostat results in increased expression of NUDT4 mRNA	12q22	A21037
Panobinostat	Approved Investigational	NWD2	57495	upregulated	panobinostat results in increased expression of NWD2 mRNA	4p14	A21037
Panobinostat	Approved Investigational	OAT	4942	upregulated	panobinostat results in increased expression of OAT mRNA	10q26.13	A21037
Panobinostat	Approved Investigational	OLA1	29789	downregulated	panobinostat results in decreased expression of OLA1 mRNA	2q31.1	A21037
Panobinostat	Approved Investigational	OLFM3	118427	upregulated	panobinostat results in increased expression of OLFM3 mRNA	1p21.1	A21037
Panobinostat	Approved Investigational	OLFML3	56944	upregulated	panobinostat results in increased expression of OLFML3 mRNA	1p13.2	A21037
Panobinostat	Approved Investigational	OPCML	4978	upregulated	panobinostat results in increased expression of OPCML mRNA	11q25	A21037
Panobinostat	Approved Investigational	OPRK1	4986	downregulated	panobinostat results in decreased expression of OPRK1 mRNA	8q11.23	A21037
Panobinostat	Approved Investigational	ORM1	5004	downregulated	panobinostat results in decreased expression of ORM1 mRNA	9q32	A21037
Panobinostat	Approved Investigational	ORM2	5005	downregulated	panobinostat results in decreased expression of ORM2 mRNA	9q32	A21037
Panobinostat	Approved Investigational	OSBPL10	114884	upregulated	panobinostat results in increased expression of OSBPL10 mRNA	3p23	A21037
Panobinostat	Approved Investigational	OVOL1	5017	upregulated	panobinostat results in increased expression of OVOL1 mRNA	11q13.1	A21037
Panobinostat	Approved Investigational	PABPC4L	132430	upregulated	panobinostat results in increased expression of PABPC4L mRNA	4q28.3	A21037
Panobinostat	Approved Investigational	PABPC5	140886	upregulated	panobinostat results in increased expression of PABPC5 mRNA	Xq21.31	A21037
Panobinostat	Approved Investigational	PAK3	5063	downregulated	panobinostat results in decreased expression of PAK3 mRNA	Xq23	A21037
Panobinostat	Approved Investigational	PAMR1	25891	downregulated	panobinostat results in decreased expression of PAMR1 mRNA	11p13	A21037
Panobinostat	Approved Investigational	PAX2	5076	upregulated	panobinostat results in increased expression of PAX2 mRNA	10q24.31	A21037

Displaying entries 56451 - 56475 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability